Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results from a Randomized, Double-Blind, Placebo-Controlled Study

Samankaltaisia teoksia

• Ziprasidone Augmentation for Anxious Depression
  Tekijä: Ionescu, Dawn F., et al.
  Julkaistu: (2016)
• A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-(L)-Methionine (SAMe) Vs. Escitalopram in Major Depressive Disorder
  Tekijä: Mischoulon, David, et al.
  Julkaistu: (2014)
• PS153. Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial
  Tekijä: Heo, Jung Yoon, et al.
  Julkaistu: (2016)
• Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression
  Tekijä: Laferton, Johannes A. C., et al.
  Julkaistu: (2018)
• A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder
  Tekijä: Brown, E. Sherwood, et al.
  Julkaistu: (2018)